The Food and Drug Administration (FDA) carried out an inspection of Materne North America Corporation in Nampa on Feb. 13 to assess foodborne biological hazards, according to data posted on the FDA’s website.
The final report found that Materne North America Corporation was not required to implement any changes to its operational management.
The FDA regularly inspects facilities nationwide to check whether workplaces and products meet FDA regulations and legal standards designed to protect public health. The outcomes of these inspections are shared with the public.
According to its website, the FDA is a federal agency chiefly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
